Thomas Cerny
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 15
- Lung Cancer Research Studies 3
- Pancreatic and Hepatic Oncology Research 3
-
- vaccines and immunoinformatics approaches 3
- Co-authors
- Florian Strasser (8 shared papers)N. Thatcher (4 shared papers)P S Hasleton (3 shared papers)Jim Heighway (2 shared papers)Ulrich Güller (9 shared papers)Markus Joerger (9 shared papers)Thomas Ruhstaller (2 shared papers)René Warschkow (7 shared papers)
- Journals
- British Journal of Cancer (6 papers)Journal of Clinical Oncology (5 papers)Lung Cancer (3 papers)Pancreas (2 papers)Annals of Surgery (2 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Thomas Cerny
53 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 121
- Oncology 705
- Pathology and Forensic Medicine 252
- Cancer Research 207
- Pharmacology 188
- Pulmonary and Respiratory Medicine 335
Countries citing papers authored by Thomas Cerny
This map shows the geographic impact of Thomas Cerny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Cerny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Cerny more than expected).
Fields of papers citing papers by Thomas Cerny
This network shows the impact of papers produced by Thomas Cerny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Cerny. The network helps show where Thomas Cerny may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Cerny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 325 | |
| 2 | 1996 | 199 | |
| 3 | 2011 | 136 | |
| 4 | 1986 | 134 | |
| 5 | Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer. | 2000 | 134 |
| 6 | 2006 | 99 | |
| 7 | 2014 | 96 | |
| 8 | 2007 | 91 | |
| 9 | 1986 | 89 | |
| 10 | 2017 | 83 | |
| 11 | 2010 | 71 | |
| 12 | 2015 | 66 | |
| 13 | 2013 | 65 | |
| 14 | 2013 | 61 | |
| 15 | 2002 | 56 | |
| 16 | 2017 | 52 | |
| 17 | 1992 | 48 | |
| 18 | 2015 | 48 | |
| 19 | 2009 | 41 | |
| 20 | 2017 | 37 |
About Thomas Cerny
Thomas Cerny is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Epidemiology, having authored 53 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Lung Cancer Research Studies (3 papers), T-cell and B-cell Immunology (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Palliative Care and End-of-Life Issues (3 papers) and vaccines and immunoinformatics approaches (3 papers). The work is most often cited by research in Oncology (705 citations), Pathology and Forensic Medicine (252 citations), Cancer Research (207 citations), Pharmacology (188 citations) and Pulmonary and Respiratory Medicine (335 citations). Thomas Cerny has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Florian Strasser, N. Thatcher, P S Hasleton, Jim Heighway, Ulrich Güller, Markus Joerger, Thomas Ruhstaller, René Warschkow, Winfried Meißner and Martin Schnelle. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Lung Cancer, Pancreas and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.